JORDAN WALD: Open Payments
NPI 1043757784 · VESTAVIA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,538 in 94 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $14 · 2025 $1,538
Food & beverage: $1,538
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $309 |
| ABBVIE INC. | 26 | $269 |
| PFIZER INC. | 12 | $257 |
| Axsome Therapeutics, Inc. | 6 | $138 |
| Lilly USA, LLC | 6 | $106 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $72 |
| AstraZeneca Pharmaceuticals LP | 4 | $70 |
| SHIELD THERAPEUTICS INC | 3 | $60 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $58 |
| Amgen Inc. | 2 | $40 |
Products named: NURTEC ODT, Wegovy, Symbravo, MOUNJARO, UBRELVY, ELIQUIS, VRAYLAR, QULIPTA.
Industry payments across AL — which companies pay providers there.
